Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | RGD Reference | Notes | Source | Original Reference(s) | ZNF135 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZNF135 mRNA | CTD | PMID:20823114 | ZNF135 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ZNF135 mRNA | CTD | PMID:32763439 | ZNF135 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF135 promoter | CTD | PMID:27901495 | ZNF135 | Human | bucladesine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZNF135 mRNA | CTD | PMID:20823114 | ZNF135 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF135 more ... | CTD | PMID:35301059 | ZNF135 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF135 more ... | CTD | PMID:35301059 | ZNF135 | Human | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of ZNF135 mRNA | CTD | PMID:18175754 | ZNF135 | Human | GSK-J4 | decreases expression | EXP | | 6480464 | GSK-J4 results in decreased expression of ZNF135 mRNA | CTD | PMID:29301935 | ZNF135 | Human | medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZNF135 mRNA | CTD | PMID:20823114 | ZNF135 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of ZNF135 mRNA | CTD | PMID:36318118 | ZNF135 | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ZNF135 mRNA | CTD | PMID:12569576 | ZNF135 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZNF135 mRNA | CTD | PMID:34032870 | ZNF135 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ZNF135 mRNA | CTD | PMID:31533062 | ZNF135 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of ZNF135 mRNA | CTD | PMID:37042841 | ZNF135 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ZNF135 gene | CTD | PMID:29154799 | ZNF135 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZNF135 mRNA | CTD | PMID:25979313 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















